What are the prevention and treatment options for Human Papillomavirus (HPV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prevention and Treatment Options for Human Papillomavirus (HPV)

HPV vaccination is the primary prevention method for HPV infection and related diseases, with routine vaccination recommended for individuals aged 9-26 years, while treatment focuses on managing HPV-related lesions rather than the infection itself. 1, 2

Prevention Strategies

HPV Vaccination

Recommended Vaccination Schedule

  • Primary target group: Girls and boys aged 11-12 years 2
  • Vaccination can begin as early as age 9 years 2
  • Catch-up vaccination recommended for:
    • All individuals aged 13-18 years who missed vaccination or need to complete the series 2
    • Individuals aged 19-26 years based on individual risk assessment and discussion with healthcare provider 2
  • Standard dosing schedule: 3 doses administered at 0,2, and 6 months 2
  • For individuals under 15 years: 2-dose series is sufficient (except for immunocompromised individuals who require 3 doses) 3

High-Risk Populations

Vaccination is particularly important for:

  • HIV-infected individuals
  • Men who have sex with men (MSM)
  • Individuals with inflammatory bowel disease
  • Women with precancerous cervical lesions
  • Patients with immunodeficiency or on immunosuppressive treatment
  • Transplant recipients
  • Patients with recurrent respiratory papillomatosis 2

Contraindications and Precautions

  • Do not administer to individuals with history of immediate hypersensitivity to yeast or vaccine components 2
  • Defer vaccination during moderate or severe acute illness 2
  • Not recommended during pregnancy; postpone remaining doses until after pregnancy 2
  • Monitor for syncope (fainting) for 15 minutes after administration, especially in adolescents 2

Other Prevention Methods

  • Barrier methods: Consistent and correct condom use reduces HPV infection risk by approximately 70%, though protection is incomplete as skin not covered by condoms remains vulnerable 1
  • Behavioral strategies:
    • Limiting number of sexual partners
    • Delaying onset of sexual activity
    • Maintaining monogamous relationships with uninfected partners 2, 1

Screening for HPV-Related Diseases

  • Regular cervical cancer screening remains essential for all women, including those who have been vaccinated 2
  • Screening should follow current guidelines for Pap testing and/or HPV testing 2
  • HPV vaccination does not replace the need for regular screening, as vaccines do not protect against all oncogenic HPV types 2

Treatment Options

For HPV Infection

  • No specific antiviral treatment exists for HPV infection itself 2
  • Treatment focuses on HPV-associated lesions rather than the infection 2

For HPV-Related Lesions

Genital Warts

Treatment options include:

  • Local removal methods:
    • Cryotherapy
    • Electrocautery
    • Laser therapy
    • Surgical excision
  • Topical pharmacologic agents 2

Precancerous Lesions and Cancers

  • Cervical, vaginal, and vulvar precancerous lesions are treated with:
    • Cryotherapy
    • Laser therapy
    • Loop electrosurgical excision procedure (LEEP)
    • Surgical excision 2
  • HPV-related cancers require standard cancer treatments (surgery, radiation, chemotherapy) based on cancer type and stage 4

Recurrent Respiratory Papillomatosis

  • Typically requires multiple surgeries to remove warts and maintain an open airway 2

Emerging Therapeutic Approaches

  • Therapeutic HPV vaccines targeting HPV oncoproteins E6 and E7 are under development for treating existing HPV infections and associated diseases 5, 6
  • Various approaches being investigated include:
    • Live-vector vaccines
    • Protein and peptide-based vaccines
    • Dendritic cell vaccines
    • DNA-based vaccines 5

Important Clinical Considerations

  • Available treatments for HPV-related lesions may reduce but likely do not eliminate infectiousness 2
  • Partner notification is not recommended for HPV infection due to its high prevalence 2
  • HPV infection can remain dormant for years before detection, so infection does not necessarily indicate recent acquisition or infidelity 1
  • Vaccination is most effective when administered before potential exposure to HPV through sexual activity 2
  • Individuals who are already sexually active or HPV-infected can still benefit from vaccination against HPV types they have not yet acquired 2

HPV prevention and management requires a comprehensive approach combining vaccination, safe sexual practices, regular screening, and appropriate treatment of HPV-related lesions to reduce morbidity and mortality from HPV-associated diseases.

References

Guideline

Human Papillomavirus Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Human Papillomavirus: Screening, Testing, and Prevention.

American family physician, 2021

Research

Human Papillomavirus-Associated Cancers.

Advances in experimental medicine and biology, 2021

Research

Vaccination Strategies for the Control and Treatment of HPV Infection and HPV-Associated Cancer.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2021

Research

Control of HPV infection and related cancer through vaccination.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.